Thapsigargin and EGTA inhibit endothelin-1-induced glucose transport.
D041721:3T3-L1 Cells; D017667:Adipocytes / Q000166:cytology / Q000378:metabolism; D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D002118:Calcium / Q000378:metabolism; D020013:Calcium Signaling; D004533:Egtazic Acid / Q000494:pharmacology*; D019332:Endothelin-1 / Q000494:pharmacology*; D005947:Glucose / Q000378:metabolism*; D051272:Glucose Transporter Type 1; D020935:MAP Kinase Signaling System; D051379:Mice; D009004:Monosaccharide Transport Proteins / Q000187:drug effects / Q000235:genetics; D019284:Thapsigargin / Q000494:pharmacology*
D019332:Endothelin-1; D051272:Glucose Transporter Type 1; D009004:Monosaccharide Transport Proteins; C495678:Slc2a1 protein, mouse; D004533:Egtazic Acid; D019284:Thapsigargin; D005947:Glucose; D002118:Calcium